NEW YORK (GenomeWeb) – Sophia Genetics announced five partnerships with UK healthcare institutions for use of the company's data analysis platform to clinically interpret genetic information. 

The deals are with Oxford University Hospital, Newcastle Medical Genetics, Aberdeen Medical Genetics, Liverpool Women's NHS Foundation Trust, and New Gene. They will use Sophia's Data Driven Medicine Platform, which employs machine learning and algorithms to analyze patients' genomic samples. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.